Sarah Cannon Research Institute SC is a clinical research site located in Nashville, Tennessee, United States 37203.
Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.
Sarah Cannon Research Institute SC has participated in 2 clinical trials.
Therapeutic areas: BRAF V600 Colorectal Cancer, Breast Cancer, Lung Cancer.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Sarah Cannon Research Institute SC has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sarah Cannon Research Institute SC has 2 clinical trials on record. Their work covers BRAF V600 Colorectal Cancer, Breast Cancer, Lung Cancer.
Sarah Cannon Research Institute SC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.